HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Domi, A. Articles by Beaud, G. Search for Related Content PubMed PubMed Citation Articles by Domi, A. Articles by Beaud, G. Agricola Articles by Domi, A. Articles by Beaud, G.

The punctate sites of accumulation of vaccinia virus early proteins are precursors of sites of viral DNA synthesis

Institut Jacques Monod (CNRS – Université Paris 6 – Université Paris 7), Tour 43, 2 place Jussieu, 75251 Paris Cedex 05, France¹

Author for correspondence: Georges Beaud. Fax +33 1 44 27 35 80. e-mail beaud{at}ijm.jussieu.fr

Several vaccinia virus early proteins (encoded by genes B1R, H5R and I3L) synthesized in the presence of an inhibitor of DNA synthesis localize, at least in part, to punctate inclusions that are visible by immunofluorescence in the cytoplasm of poxvirus-infected cells. It is shown that these inclusions contain DNA (visualized by DAPI staining of the infected cells) and that the number of inclusions is proportional to the amount of input virus. Their mean diameter (about 680 nm) was larger than that of purified vaccinia virus particles. When the inhibition of DNA synthesis was reversed, incorporation of BrdU into the B1R particles was demonstrated after labelling for 30 min, suggesting that these cytoplasmic focal sites correspond to viral DNA replication complexes that have initiated normally but are inhibited at the step of DNA chain elongation. These experiments suggest strongly that these inclusions are the precursors of the virosomes.

This article has been cited by other articles:

				S. M. D'Costa, T. W. Bainbridge, and R. C. Condit Purification and Properties of the Vaccinia Virus mRNA Processing Factor J. Biol. Chem., February 29, 2008; 283(9): 5267 - 5275. [Abstract] [Full Text] [PDF]

				K. A. Boyle and P. Traktman Members of a Novel Family of Mammalian Protein Kinases Complement the DNA-Negative Phenotype of a Vaccinia Virus ts Mutant Defective in the B1 Kinase J. Virol., February 15, 2004; 78(4): 1992 - 2005. [Abstract] [Full Text] [PDF]

				S. Welsch, L. Doglio, S. Schleich, and J. Krijnse Locker The Vaccinia Virus I3L Gene Product Is Localized to a Complex Endoplasmic Reticulum-Associated Structure That Contains the Viral Parental DNA J. Virol., May 15, 2003; 77(10): 6014 - 6028. [Abstract] [Full Text] [PDF]

				M. Mallardo, E. Leithe, S. Schleich, N. Roos, L. Doglio, and J. Krijnse Locker Relationship between Vaccinia Virus Intracellular Cores, Early mRNAs, and DNA Replication Sites J. Virol., April 16, 2002; 76(10): 5167 - 5183. [Abstract] [Full Text] [PDF]

				N. Tolonen, L. Doglio, S. Schleich, and J. K. Locker Vaccinia Virus DNA Replication Occurs in Endoplasmic Reticulum-enclosed Cytoplasmic Mini-Nuclei Mol. Biol. Cell, July 1, 2001; 12(7): 2031 - 2046. [Abstract] [Full Text] [PDF]